Mineralized bone loss at different sites in dialysis patients: Implications for prevention

Journal of the American Society of Nephrology

Volumn 9, Issue 7, 1998, Pages 1225-1233

  Schober, Hans Christoff ^a   Han, Z H ^b   Foldes, A Joseph ^c   Shih, Mei Shu ^d   Rao, D Sudhaker ^b   Balena, Raffaella ^e   Parfitt, A Michael ^f,g  

^a Division of Internal Medicine   (Germany)

^b HENRY FORD HOSPITAL   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d CURIS INC   (United States)

^e Proctor and Gamble (HABC) Ltd   (United Kingdom)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE ATROPHY; BONE MINERALIZATION; BONE TISSUE; FEMALE; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORPHOMETRICS; OSTEITIS FIBROSA; OSTEOMALACIA; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY;

EID: 0031801035     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Malluche H, Faugere M-C: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38: 193-211, 1990
2. Sherrard D, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton S, Segre G: The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 43: 436-442, 1993
3. Parfitt AM, Duncan H: Metabolic bone disease affecting the spine. In: The Spine, 2nd Ed., edited by Rothman R, Simeone F, Philadelphia, W. B. Saunders, 1982, pp 775-905
4. Martin RB, Burr DB: Structure, Function, and Adaptation of Compact Bone, New York, Raven, 1989
5. Parfitt AM: Osteomalacia and related disorders. In: Metabolic Bone Disease and Clinically Related Disorders, 3rd Ed., edited by Avioli LV, Krane SM, Philadelphia, W. B. Saunders, 1997, pp 327-386
6. Naito M, Ogata K, Shiota E, Oyama M: Amyloid bone cysts of the femoral neck: Impending fractures treated by curettage and bone grafting. J Bone Jt Surg 76B: 922-925, 1994
7. Piraino B, Chen T, Cooperstein L, Segre G, Puschett J: Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30: 57-62, 1988
8. Copley JB, Hui SL, Leapman S, Slemenda CW, Johnston CC Jr: Longitudinal study of bone mass in end-stage renal disease patients: Effects of parathyroidectomy for renal osteodystrophy. J Bone Miner Res 8: 415-422, 1993
9. Parfitt AM: Surface specific bone remodeling in health and disease. In: Clinical Disorders of Bone and Mineral Metabolism, edited by Kleerekoper M, Krane S, New York, Mary Ann Liebert Publishers, 1989, pp 7-14
10. Eeckhout E, Verbeelen D, Sennesael J, Kaufman L, Jonckheer MH: Monitoring of bone mineral content in patients on regular hemodialysis. Nephron 52: 158-161, 1989
11. Foldes J, Parfitt AM, Shih M-S, Rao DS, Kleerekoper M: Structural and geometric changes in iliac bone: Relationship to normal aging and osteoporosis. J Bone Miner Res 6: 759-766, 1991
12. Parfitt AM, Rao DS, Stanciu J, Villanueva AR, Kleerekoper M, Frame B: Irreversible bone loss in osteomalacia: Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest 76: 2403-2412, 1985
13. Parfitt AM: Metacarpal cortical dimensions in hypoparathyroidism, primary hyperparathyroidism and chronic renal failure. Calcif Tissue Res 22[Suppl]: 542-544, 1977
14. Rao DS: Practical approach to bone biopsy. In: Bone Histomorphometry: Techniques and Interpretations, edited by Recker R, Boca Raton, CRC Press, 1983, pp 3-11
15. Parfitt AM: The actions of parathyroid hormone on bone: Relation to bone remodelling and turnover, calcium homeostasis and metabolic bone disease. III. PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism. Metabolism 25: 1033-1069, 1976
16. Han Z-H, Palnitkar S, Rao DS, Nelson D, Parfitt AM: Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res 11: 1967-1975, 1996
17. Han Z-H, Palnitkar S, Rao DS, Nelson D, Parfitt AM: Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: Implications for mechanisms of bone loss. J Bone Miner Res 12: 498-508, 1997
18. Parfitt AM, Podenphant J, Villanueva AR, Frame B: Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: A bone histomorphometric study. Bone 6: 211-220, 1985
19. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR: Bone histomorphometry nomenclature, symbols and units: Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610, 1987
20. Parfitt AM, Stanciu J: Distinctive tetracycline based bone histomorphometric features of aluminum-related osteomalacia [Abstract]. Miner Electrolyte Metab 11: 281, 1985
21. Maloney NA, Ott SM, Alfrey AC, Miller NL, Coburn JW, Sherrard DJ: Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 99: 206-216, 1982
22. Parfitt AM: Interpretation of bone densitometry measurements: The disadvantages of a percentage scale and a discussion of available alternatives. J Bone Miner Res 5: 537-540, 1990
23. Altman DG: Practical Statistics for Medical Research, London, Chapman and Hall, 1991
24. Visser WJ, Roelofs JMM, Peters JPJ, Lentferink MHF, Duursma SA: Sampling variation in bone histomorphometry. In: Bone Histomorphometry: Third International Workshop, edited by Jee WSS, Parfitt AM, Paris, Armour-Montagu, 1981, pp 429-434
25. Podenphant J, Herss Nielsen V-A, Riis BJ, Gotfredsen A, Christiansen C: Bone mass, bone structure and vertebral fractures in osteoporotic patients. Bone 8: 127-130, 1987
26. Parfitt AM: The morphologic basis of bone mineral measurements: Transient and steady state effects of treatment in osteoporosis [Editorial]. Miner Electrolyte Metab 4: 273-287, 1980
27. Heaf JG, Preben J, Podenphant J, Andersen JR: Noninvasive diagnosis of uremic osteodystrophy: Uses and limitations. Am J Nephrol 7: 203-211, 1987
28. Parfitt AM: The composition, structure and remodeling of bone: A basis for the interpretation of bone mineral measurements. In: Bone Mineral Measurements by Photon Absorptiometry: Methodological Problems, edited by Dequeker J, Geusens P, Wahner HW, Leuven, Belgium, Leuven University Press, 1988, pp 9-28
29. Vesterby A: Star volume of marrow space and trabeculae in iliac crest: Sampling procedure and correlation to star volume of first lumbar vertebra. Bone 11: 149-156, 1990
30. Eventov I, Frisch B, Cohen Z, Hammel I: Osteopenia, hematopoiesis, and bone remodelling in iliac crest and femoral biopsies: A prospective study of 102 cases of femoral neck fractures. Bone 12: 1-6, 1991
31. Parfitt AM: Bone remodeling: Relationship to the amount and structure of bone and the pathogenesis and prevention of fractures. In: Osteoporosis: Etiology, Diagnosis and Management, edited by Riggs BL, Melton LJ, New York, Raven, 1988, pp 45-94
32. Chan Y-L, Furlong TJ, Cornish CJ, Posen S: Dialysis osteodystrophy: A study involving 94 patients. Medicine 64: 296-309, 1985
33. Parfitt AM, Rao DS, Kleerekoper M, Walczak N, Levin N, Oliver I, Frame B: Midshaft and distal radius bone mineral in primary and secondary hyperparathyroidism: Diagnostic value and response to treatment. Presented at the Fourth International Conference on Bone Measurement, 1980. U.S. Department of Health and Human Services, National Institutes of Health 80, Bethesda, MD, 1983, pp 183-190
34. Bianchi ML, Colantonio G, Montesano A, Trevisan C, Ortolani S, Rossi R, Buccianti G: Bone mass status in different degrees of chronic renal failure. Bone 13: 225-228, 1992
35. Gabay C, Ruedin P, Slosman D, Bonjour J-P, Leski M, Rizzoli R: Bone mineral density in patients with end-stage renal failure. Am J Nephrol 13: 115-123, 1993
36. Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ: Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 28: 515-522, 1996
37. Johnston CC Jr, Melton LJ, Lindsay R, Eddy DM: Clinical indications for bone mass measurements: A report from the Scientific Advisory Board of the National Osteoporosis Foundation. J Bone Miner Res 4[Suppl 2]: 1-28, 1989
38. Gupta A, Kallenbach LR, Divine GW: Increased risk of hip fractures in U.S. Medicare end-stage renal disease patients [Abstract]. J Bone Miner Res 12[Suppl]: S274, 1997
39. Kleerekoper M, Villanueva AR, Mathews CHE, Rao DS, Pumo B, Parfitt AM: PTH-mediated bone loss in primary and secondary hyperparathyroidism. In: Clinical Disorders of Bone and Mineral Metabolism, edited by Frame B, Potts JT Jr, Amsterdam, Excerpta Medica, 1983, pp 200-203
40. Parfitt AM: Accelerated cortical bone loss: Primary and secondary hyperparathyroidism. In: Current Concepts of Bone Fragility, edited by Uhthoff H, New York, Springer-Verlag, 1986, pp 279-285
41. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM: Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: Evidence for biphasic disease course. J Clin Endocrinol 109: 959-962, 1988
42. Parfitt AM, Massry SG, Winfield AT: Osteopenia and fractures occurring during maintenance hemodialysis: A new form of renal osteodystrophy. Clin Orthop 87: 287-302, 1972
43. Henderson RG, Russell RGG, Earnshaw MJ, Ledingham JGG, Oliver DO, Woods CG: Loss of metacarpal and iliac bone in chronic renal failure: Influence of haemodialysis, parathyroid activity, type of renal disease, physical activity, and heparin consumption. Clin Sci 56: 317-324, 1979
44. Przedlacki J, Manelius J, Huttunen K: Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure. Nephron 69: 433-437, 1995
45. Rudnicki M, Hyldstrup L, Petersen LJ, Højsted J, Transbøl I: Effect of oral calcium on noninvasive indices of bone formation and bone mass in hemodialysis patients: A randomized double-blind placebo-controlled study. Miner Electrolyte Metab 20: 130-134, 1994
46. Akiba T, Kurihara A, Yamada T, Ogasawara M, Marumo F: Intravenous calcitriol can increase bone mass in hemodialysis patients with osteitis fibrosa. Miner Electrolyte Metab 21: 109-113, 1995
47. Parfitt AM, Kleerekoper M, Rao DS, Stanciu J, Villanueva AR: Cellular mechanisms of cortical thinning in primary hyperparathyroidism (PHPT) [Abstract]. J Bone Miner Res 2[Suppl 1]: 384, 1987
48. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, deBonis E, Darias E, Gonzalez-Posada JM, Losada M, Rufino M, Felsenfeld AJ, Rodriguez M: Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47: 1434-1442, 1995
49. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS: Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 57: 329-335, 1995
50. Hamdy NAT, Kanis JA, Beneton MNC, Brown CB, Juttmann JR, Jordans JGM, Josse S, Meyrier A, Lins RL, Fairey IT: Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. Br Med J 310: 358-363, 1995